Developed flow panels and supported 2 clinical trial programs for biomarker assay development by immunophenotyping for finding biomarkers
Managed and worked with team for discovery and platform development of biologics for acute myeloid leukemia (AML), and other sloid tumors
Developed and interpreted in vivo and in vitro assays and data to support drug discovery programs resulting in filing IND
Independently designed, conducted, interpreted, and reported in vitro studies using wide range of established methodologies
Played instrumental role in bioanalytical assay development for clinical research and validated analytical methods for measuring soluble drug targets using various matrices; resulted in successful completion of preclinical and clinical studies
Initiated and led new strategies of CAR-Macrophage/CAR-T development for solid tumor treatments, effective delivery to in vivo mouse model
Proactively participated in manuscript writing for publications, preparation of IND files, and tech-report writing
Actively participated in and supported antibody-drug conjugate (ADC) development program; worked in cross-functional team to develop in vivo models for testing efficacy of different ADC compounds; resulted in vivo model development
Worked closely with corporate partners to support preclinical, translational, and clinical development of cancer therapeutics.
Postdoctoral Fellow
CHILDREN’S NATIONAL HOSPITAL
10.2020 - 12.2021
Nanoparticle Mediated Drug Delivery: Led projects and provided data for different grant proposals
Developed pathway of common chemotherapy-induced immune cell migration; developed strategies for nanoparticle-mediated antigen and drug delivery
Designed method to send chemotherapeutic drugs and immune checkpoint inhibitors to overcome blood-brain barrier for the treatment of glioma
Actively participated in a collaborative project for investigation of T-cell functions by chip-based technologies.
Postdoctoral Fellow
GEORGETOWN UNIVERSITY
12.2018 - 10.2020
Tumor Model Development/Immunophenotyping: Led various projects on small molecule mediated cancer immunotherapy
Conducted multiple projects on drug discovery and immunomodulatory effects of small molecule inhibitors
Developed projects related to T-regulatory cell manipulation and trans differentiation to other T-helper cells (Th17, Th1, Th2)
Executed combination immunotherapy with tumor-specific vaccine and OX40-anti-PD-1, HDAC inhibitor
Actively participated in research on T-cell memory response by MEK inhibitor, with colleagues in lab and published manuscript in nature immunology.
Postdoctoral Fellow
LEUKEMIA BIOLOGY SECTION
02.2014 - 11.2018
Led myeloid leukemia research projects using transgenic mouse models; discovered alternative origin of known leukemia
Led Lin28b (let7 group miRNA regulator) and H3K27 involvement in CD4 T-cell leukemia
Actively participated in research project on progenitor B-1 cell-derived B-cell acute lymphoblastic lymphoma and jointly published manuscript
Implemented next-generation sequencing to learn how collaborative mutation helps in the development of leukemia
Collaborated and investigated Igh gene rearrangements in SCL-LMO1 transgenic mice tissue samples that showed potential to develop B cells from thymic progenitors.
Postdoctoral Fellow
USUHS
02.2013 - 01.2014
QRT-PCR Data Acquisition/Analysis: Developed assays to support cystic fibrosis research; jointly discovered micro-RNA mediated rescue of mutant CFTR(F508del-CFTR) from endoplasmic reticulum to cell membrane; restored function of CFTR protein in cystic fibrosis.